The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism: A Double-blind, Placebo-Controlled Study
Abstract
BACKGROUND: Naltrexone and acamprosate have been shown to be effective in relapse prevention of alcoholism via different pharmacologic mechanisms. Since it remains uncertain whether both substances are equally efficient and whether a combination of both drugs potentiates the efficacy, we conducted the first published controlled study comparing and combining both compounds. METHODS: After detoxification, 160 patients with alcoholism participated in a randomized, double-blind, placebo-controlled protocol. Patients received naltrexone, acamprosate, naltrexone plus acamprosate, or placebo for 12 weeks. Patients were assessed weekly by interview, self-report, questionnaires, and laboratory screening. Time to first drink, time to relapse, and the cumulative abstinence time were the primary outcome measures. RESULTS: Naltrexone, acamprosate, and the combined medication were significantly more effective than placebo. Comparing the course of nonrelapse rates between naltrexone and acamprosate, the naltrexone group showed a tendency for a better outcome regarding time to first drink and time to relapse. The combined medication was most effective with significantly lower relapse rates than placebo and acamprosate but not naltrexone. CONCLUSIONS: The results of this study support the efficacy of pharmacotherapeutic strategies in the relapse prevention of alcoholism. Naltrexone and acamprosate, especially in combination, considerably enhance the potential of relapse prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Anton, R. F., Moak, D. H., & Latham, P. (1995) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01475.x · Cited by 677
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Relapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479
Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1758 · Cited by 425
A three-pathway psychobiological model of craving for alcohol.
Verheul, R., van den Brink, W., & Geerlings, P. (1999) · Alcohol and Alcoholism · doi:10.1093/alcalc/34.2.197 · Cited by 414
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
Kranzler, H. R., & Van Kirk, J. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02356.x · Cited by 390
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
Whitworth, A. B., Oberbauer, H., Fleischhacker, W. W., Lesch, O. M., Walter, H., Nimmerrichter, A., Platz, T., Fischer, F., & Potgieter, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91682-7 · Cited by 320
Chick, J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.6.587 · Cited by 310
DOUBLE-BLIND RANDOMIZED MULTICENTRE TRIAL OF ACAMPROSATE IN MAINTAINING ABSTINENCE FROM ALCOHOL
(1995) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045720 · Cited by 273
Samson, H. H., & Harris, R. A. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90065-e · Cited by 265
Monti, P. M., Rohsenow, D. J., Swift, R. M., Gulliver, S. B., Colby, S. M., Mueller, T. I., Brown, R. A., Gordon, A., Abrams, D. B., Niaura, R. S., et al. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200111000-00011 · Cited by 233
Streeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228 · cited 2×
“Anton et al9 also added support to the hypothesis that naltrexone might be efficacious in the maintenance of abstinence, and moreover, this hypothesis was reinforced by the results of the metaanalyses by Kranzler and Van Kirk17 and Streeton and Whelan.18 Craving as one possible target of drug effects plays a crucial r…”
ResultHeinälä, P., Alho, H., Kiianmaa, K., Lönnqvist, J., Kuoppasalmi, K., & Sinclair, J. D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00006 · Cited by 226
Chick, J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.176 · Cited by 213
Croop, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830240090013 · Cited by 211
Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled Trial
Kranzler, H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00135-9 · Cited by 209
Naltrexone for alcohol dependence: a randomized controlled trial
Morris, P. L. P., Hopwood, M., Whelan, G., Gardiner, J., & Drummond, E. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961115654.x · Cited by 200
Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study
Besson, J., Aeby, F., Kasas, A., Lehert, P., & Potgieter, A. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04295.x · Cited by 192
ACAMPROSATE APPEARS TO DECREASE ALCOHOL INTAKE IN WEANED ALCOHOLICS
LHUINTRE, J. P., MOORE, N., TRAN, G., STERU, L., LANGRENON, S., DAOUST, S., PAROT, P., LADURE, P., LIBERT, C., BOISMARE, F., et al. (1990) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045057 · Cited by 189
Naltrexone??s Effect on Cue-Elicited Craving Among Alcoholics in Treatment
Monti, P. M., Rohsenow, D. J., Hutchison, K. E., Swift, R. M., Mueller, T. I., Colby, S. M., Brown, R. A., Gulliver, S. B., Gordon, A., & Abrams, D. B. (1999) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199908000-00013 · Cited by 188
Boismare, F., Daoust, M., Moore, N., Saligaut, C., Lhuintre, J. P., Chretien, P., & Durlach, J. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80020-9 · Cited by 184
Pelc, I., Verbanck, P., Bon, O. L., Gavrilovic, M., Lion, K., & Lehert, P. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.1.73 · Cited by 184
Acamprosate in alcohol dependence: how does it work?
LITTLETON, J. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 178
Zeise, M. L., Kasparov, S., Capogna, M., & Zieglgänsberger, W. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90682-8 · Cited by 175
ABILITY OF CALCIUM BIS ACETYL HOMOTAURINE, A GABA AGONIST, TO PREVENT RELAPSE IN WEANED ALCOHOLICS
Lhuintre, J.-P., Moore, N., Saligaut, C., Boismare, F., Daoust, M., Chretien, P., Tran, G., & Hillemand, B. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91615-0 · Cited by 166
Tempesta, E. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.202 · Cited by 154
Rammes, G., Mahal, B., Putzke, J., Parsons, C. G., Spielmanns, P., Pestel, E., Spanagel, R., Zieglgänsberger, W., & Schadrack, J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00008-9 · Cited by 148
Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence
Oslin, D. W., Liberto, J. G., O'Brien, J. T., Krois, S., & Norbeck, J. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00007 · Cited by 143
Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal processes.
Grant, K. A., & Dm, L. (1995) · PubMed · Cited by 134
Acamprosate treatment in a long-term community-based alcohol rehabilitation programme
Poldrugo, F. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02873.x · Cited by 133
Die OCDS-G: Psychometrische Kennwerte der deutschen Version der Obsessive Compulsive Drinking Scale
Mann, K. F., & Ackermann, K. (2000) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/suc.2000.46.2.90 · Cited by 132
Does urge to drink predict relapse after treatment?
Rohsenow, D. J., & Monti, P. M. (1999) · PubMed Central · Cited by 128
Wilde, M. I., & Wagstaff, A. J. (1997) · Drugs · doi:10.2165/00003495-199753060-00008 · Cited by 122
NALTREXONE VERSUS ACAMPROSATE: ONE YEAR FOLLOW-UP OF ALCOHOL DEPENDENCE TREATMENT
Rubio, G. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.5.419 · Cited by 116
Schuckit, M. A., Smith, T. L., Danko, G. P., Bucholz, K. K., Reich, T., & Bierut, L. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1084 · Cited by 115
PHARMACOTHERAPY OF ALCOHOLISM: GAPS IN KNOWLEDGE AND OPPORTUNITIES FOR RESEARCH
Kranzler, H. R. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.6.537 · Cited by 106
Acamprosate and Prevention of Relapse in Alcoholics
Geerlings, P. J., Ansoms, C., & van den Brink, W. (2009) · European Addiction Research · doi:10.1159/000259166 · Cited by 99
Gewiss, M., Heidbreder, C. A., Opsomer, L., DURBIN, P., & Witte, P. D. (1991) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045093 · Cited by 98
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption
Stromberg, M. F., Mackler, S. A., Volpicelli, J. R., & O’Brien, C. P. (2001) · Alcohol · doi:10.1016/s0741-8329(00)00137-3 · Cited by 81
Effect of naltrexone on human alcohol consumption.
Swift, R. M. (1995) · PubMed · Cited by 70
Opioid Involvement in Alcohol Drinkinga
Froehlich, J. C., & Li, T. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb19817.x · Cited by 67
Alcohol drinking in rats during and following morphine injections
Volpicelli, J. R., Ulm, R. R., & Hopson, N. (1991) · Alcohol · doi:10.1016/0741-8329(91)90401-h · Cited by 60
[Acamprosate--a stabilizing factor in long-term withdrawal of alcoholic patients].
Ladewig, D., Knecht, T., Leher, P., & Fendl, A. (1993) · PubMed · Cited by 50
[Does acamprosate diminish the appetite for alcohol in weaned alcoholics?].
Roussaux, J. P., Hers, D., & Ferauge, M. (1996) · PubMed · Cited by 49
Psychotherapeutic Considerations in Pharmacological Trials
O’Malley, S. S., & Carroll, K. M. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01185.x · Cited by 32
Naltrexone in the treatment of male alcoholics - an effectiveness study in Singapore
Lee, A. M., Tan, S., Lim, D., Winslow, R. M., Wong, K. E., Allen, J., Hall, W., & Parker, G. B. (2001) · Drug and Alcohol Review · doi:10.1080/09595230124192 · Cited by 28
Neurobehavioral aspects of the pharmacotherapy of alcohol dependence.
Anton, R. F., Hr, K., & Meyer, R. E. (1995) · PubMed · Cited by 27
Meta-Analysis of Pharmacotherapeutic Trials
Schoechlin, C., & Engel, R. R. (2000) · Handbooks of pharmacology and toxicology · doi:10.1201/9781420036961.ch31 · Cited by 9
Cited by
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Schuckit, M. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60009-x · Cited by 712
Saitz, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042262 · Cited by 599
Metadata
- Authors
- Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., Kämpf, P., Stracke, R., Baehr, M., Naber, D., & Wiedemann, K.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2003-01-01
- Volume
- 60
- Issue
- 1
- Pages
- 92
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2157113531
- Cited by
- 400
- References
- 52
- FWCI
- 28.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.